GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Other Gross PPE

Yumanity Therapeutics (FRA:8IY) Other Gross PPE : €0.45 Mil (As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Other Gross PPE?

Yumanity Therapeutics's Other Gross PPE for the quarter that ended in Sep. 2022 was €0.45 Mil.

Yumanity Therapeutics's quarterly Other Gross PPE declined from Mar. 2022 (€9.32 Mil) to Jun. 2022 (€0.84 Mil) and declined from Jun. 2022 (€0.84 Mil) to Sep. 2022 (€0.45 Mil).

Yumanity Therapeutics's annual Other Gross PPE increased from Dec. 2019 (€2.44 Mil) to Dec. 2020 (€20.84 Mil) but then declined from Dec. 2020 (€20.84 Mil) to Dec. 2021 (€17.60 Mil).


Yumanity Therapeutics Other Gross PPE Historical Data

The historical data trend for Yumanity Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Other Gross PPE Chart

Yumanity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21
Other Gross PPE
2.44 20.84 17.60

Yumanity Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.30 17.60 9.32 0.84 0.45

Yumanity Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Yumanity Therapeutics (FRA:8IY) Business Description

Traded in Other Exchanges
N/A
Address
40 Guest Street, Suite 4410, Boston, MA, USA, 02135
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines